Changes in Hong Kong stocks | Most brain concept stocks have risen, and semi-invasive brain-computer interface products will receive regulatory approval one after another. Agencies say the market space is more flexible in the long term

The Zhitong Finance App learned that most brain computer concept stocks rose. As of press release, Nanjing Panda Electronics (00553) rose 11.29% to HK$4.04; Brain Aurora-B (06681) rose 6.63% to HK$1.77; and Minimally Invasive Brain Science (02172) rose 2.97% to HK$9.37.

According to the news, recently, the American startup Science Corp. has been approved to sell a retinal chip that can help patients with “map-like atrophy” (GA) recover part of their vision in the European Union. This is the first time that an American brain-computer interface (BCI) company introduced related devices to the patient market on a large scale, and it is also an important milestone in the company's commercialization of brain-computer interfaces. According to reports, the PRIMA system is a semi-invasive brain-computer interface. The technical principle is that subretinal photovoltaic implants are equipped with special glasses. The glasses project near-infrared light onto the implant and convert it into electrical stimulation signals, which directly activate residual retinal nerve cells to restore functional central vision.

Zheshang Securities said that at this stage, semi-intrusive brain-computer interface products will receive regulatory approval one after another, leading to market-based testing. The bank believes that the brain-computer interface market space may have taken shape in the medium term and is more flexible in the long term. Considering the implementation of hardware and software, the global brain-computer interface market is expected to grow from US$2.41 billion in 2025 to US$12.11 billion in 2035. The compound annual growth rate during the forecast period (until 2035) is 15.8%, with plenty of room for long-term growth.